E-LIB Suche - Ergebnisse für: Turner, David C.

1

Population pharmacokinetics and CD20 binding dynamics for m..:

Bender, Brendan ; Li, Chi‐Chung ; Marchand, Mathilde...
Clinical and Translational Science. 17 (2024) 6 - p. , 2024

2

Model‐based meta‐analysis of non‐small cell lung cancer wit..:

Turner, David C. ; Wada, Russ ; Zhou, Helen...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 11 - p. 1751-1763 , 2023

Link: https://doi.org/10.1002/..

3

Activating Inducible T-cell Costimulator Yields Antitumor A..:

Yadavilli, Sapna ; Waight, Jeremy D. ; Brett, Sara...
Cancer Research Communications. 3 (2023) 8 - p. 1564-1579 , 2023

Link: https://doi.org/10.1158/..

4

Pharmacokinetics of biologics in gastric cancer:

Li, Junyi ; Turner, David C. ; Li, Feifei...
Clinical and Translational Science. 16 (2023) 4 - p. 564-574 , 2023

Link: https://doi.org/10.1111/..

5

Biomarker correlates with response to NY-ESO-1 TCR T cells ..:

Gyurdieva, Alexandra ; Zajic, Stefan ; Chang, Ya-Fang...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

6

Immunogenicity of pembrolizumab in patients with advanced t..:

van Vugt, Marianne J. H. ; Stone, Julie A. ; De Greef, "Rik" H. J. M. M....
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

7

Time dependent pharmacokinetics of pembrolizumab in patient..:

Li, Hongshan ; Yu, Jingyu ; Liu, Chao...
Journal of Pharmacokinetics and Pharmacodynamics. 44 (2017) 5 - p. 403-414 , 2017

Link: https://doi.org/10.1007/..

8

An open-label, two-stage, phase II study of bevacizumab and..:

DeWire, Mariko ; Fouladi, Maryam ; Turner, David C....
Journal of Neuro-Oncology. 123 (2015) 1 - p. 85-91 , 2015

Link: https://doi.org/10.1007/..

9

A phase I trial and PK study of cediranib (AZD2171), an ora..:

Kieran, Mark W. ; Chi, Susan ; Goldman, Stewart...
Child's Nervous System. 31 (2015) 9 - p. 1433-1445 , 2015

Link: https://doi.org/10.1007/..

10

Phase I study of 5-fluorouracil in children and young adult..:

Wright, Karen D. ; Daryani, Vinay M. ; Turner, David C....
Neuro-Oncology. 17 (2015) 12 - p. 1620-1627 , 2015

Link: https://doi.org/10.1093/..

11

Population PharmacokineticPharmacodynamic Modeling of Caffe..:

Burns, Rebecca N. ; Chaturvedula, Ayyappa ; Turner, David C...
Pharmacology & Pharmacy. 5 (2014) 4 - p. 444-454 , 2014

Link: https://doi.org/10.4236/..

12

Determination of crizotinib in human and mouse plasma by li..:

Roberts, Michael S. ; Turner, David C. ; Broniscer, Alberto.
Journal of Chromatography B. 960 (2014) - p. 151-157 , 2014

Link: https://doi.org/10.1016/..

13

Phase I and pharmacokinetic trial of PTC299 in pediatric pa..:

Packer, Roger J. ; Rood, Brian R. ; Turner, David C....
Journal of Neuro-Oncology. 121 (2014) 1 - p. 217-224 , 2014

Link: https://doi.org/10.1007/..

14

Determination of crenolanib in human serum and cerebrospina..:

Roberts, Michael S. ; Turner, David C. ; Owens, Thandranese S....
Journal of Chromatography B. 929 (2013) - p. 1-5 , 2013

Link: https://doi.org/10.1016/..

15

Understanding pharmacokinetic food effects using molecular ..:

Turner, David C. ; Yin, Fuchang ; Kindt, James T..
Biopharmaceutics & Drug Disposition. 33 (2012) 9 - p. 510-521 , 2012

Link: https://doi.org/10.1002/..